» Articles » PMID: 39210505

CycPeptMP: Enhancing Membrane Permeability Prediction of Cyclic Peptides with Multi-level Molecular Features and Data Augmentation

Overview
Journal Brief Bioinform
Specialty Biology
Date 2024 Aug 29
PMID 39210505
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclic peptides are versatile therapeutic agents that boast high binding affinity, minimal toxicity, and the potential to engage challenging protein targets. However, the pharmaceutical utility of cyclic peptides is limited by their low membrane permeability-an essential indicator of oral bioavailability and intracellular targeting. Current machine learning-based models of cyclic peptide permeability show variable performance owing to the limitations of experimental data. Furthermore, these methods use features derived from the whole molecule that have traditionally been used to predict small molecules and ignore the unique structural properties of cyclic peptides. This study presents CycPeptMP: an accurate and efficient method to predict cyclic peptide membrane permeability. We designed features for cyclic peptides at the atom-, monomer-, and peptide-levels and seamlessly integrated these into a fusion model using deep learning technology. Additionally, we applied various data augmentation techniques to enhance model training efficiency using the latest data. The fusion model exhibited excellent prediction performance for the logarithm of permeability, with a mean absolute error of $0.355$ and correlation coefficient of $0.883$. Ablation studies demonstrated that all feature levels contributed and were relatively essential to predicting membrane permeability, confirming the effectiveness of augmentation to improve prediction accuracy. A comparison with a molecular dynamics-based method showed that CycPeptMP accurately predicted peptide permeability, which is otherwise difficult to predict using simulations.

Citing Articles

MultiCycPermea: accurate and interpretable prediction of cyclic peptide permeability using a multimodal image-sequence model.

Wang Z, Chen Y, Shang Y, Yang X, Pan W, Ye X BMC Biol. 2025; 23(1):63.

PMID: 40016695 PMC: 11866622. DOI: 10.1186/s12915-025-02166-2.


PepTune: Generation of Therapeutic Peptides with Multi-Objective-Guided Discrete Diffusion.

Tang S, Zhang Y, Chatterjee P ArXiv. 2025; .

PMID: 39764410 PMC: 11703324.


Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.

Wu K, Kwon S, Zhou X, Fuller C, Wang X, Vadgama J Int J Mol Sci. 2024; 25(23.

PMID: 39684832 PMC: 11642056. DOI: 10.3390/ijms252313121.


Peptide-aware chemical language model successfully predicts membrane diffusion of cyclic peptides.

Feller A, Wilke C bioRxiv. 2024; .

PMID: 39149303 PMC: 11326283. DOI: 10.1101/2024.08.09.607221.

References
1.
Kosugi T, Ohue M . Design of Cyclic Peptides Targeting Protein-Protein Interactions Using AlphaFold. Int J Mol Sci. 2023; 24(17). PMC: 10487914. DOI: 10.3390/ijms241713257. View

2.
Choo H, Wee J, Shen C, Xia K . Fingerprint-Enhanced Graph Attention Network (FinGAT) Model for Antibiotic Discovery. J Chem Inf Model. 2023; 63(10):2928-2935. DOI: 10.1021/acs.jcim.3c00045. View

3.
Frost J, Scully C, Yudin A . Oxadiazole grafts in peptide macrocycles. Nat Chem. 2016; 8(12):1105-1111. DOI: 10.1038/nchem.2636. View

4.
Maziarka L, Majchrowski D, Danel T, Gainski P, Tabor J, Podolak I . Relative molecule self-attention transformer. J Cheminform. 2024; 16(1):3. PMC: 10765783. DOI: 10.1186/s13321-023-00789-7. View

5.
Hopping G, Kellock J, Barnwal R, Law P, Bryers J, Varani G . Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers. Elife. 2014; 3:e01681. PMC: 4091096. DOI: 10.7554/eLife.01681. View